AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12641601 — intervention group
Group type: EXPERIMENTAL
Intervention: VbX+ (squatting exercise with vibration)
Number of subjects: 19
Study 12641601 — intervention group
Group type: COMPARATOR
Intervention: VbX- (squatting exercise without vibration)
Number of subjects: 19
Study 12641601 — intervention group
Group type: EXPERIMENTAL
Intervention: VbX+
Number of subjects: 19
Study 12641601 — intervention group
Group type: COMPARATOR
Intervention: VbX-
Number of subjects: 19
Study 10671664 — intervention group
Group type: EXPERIMENTAL
Intervention: FPLC chemotherapy
Number of subjects: 60
Study 10671664 — intervention group
Group type: COMPARATOR
Intervention: Control group (no FPLC chemotherapy)
Number of subjects: 60
Study 9174182 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefmenoxime
Number of subjects: 43
Study 9174182 — intervention group
Group type: COMPARATOR
Intervention: Ciprofloxacin or Ceftazidime
Number of subjects: 43
Study 8445428 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed intensification (Delint) phase of therapy
Number of subjects: 1600
Study 8445428 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard three-drug induction and Delint
Number of subjects: 1600
Study 8445428 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal methotrexate (IT MTX) during all phases of therapy
Number of subjects: 1600
Study 8445428 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive induction, Delint, and CXRT
Number of subjects: 1600
Study 8445428 — intervention group
Group type: COMPARATOR
Intervention: Control regimen
Number of subjects: 1600
Study 3731891 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid meal of 317 kcal (group 1)
Number of subjects: 32
Study 3731891 — intervention group
Group type: COMPARATOR
Intervention: Placebo medication (group 2)
Number of subjects: 32
Study 29402570 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma question prompt list with video intervention
Number of subjects: 359
Study 29402570 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 359
Study 26501498 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral conjoint therapy (CBCT) for PTSD
Number of subjects: 39
Study 26501498 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (control group)
Number of subjects: 39
Study 24794367 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (6 mg/kg of body weight)
Number of subjects: 361
Study 24794367 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 361
Study 24330669 — intervention group
Group type: EXPERIMENTAL
Intervention: Early childhood caries (ECC) intervention consisting of dental care during pregnancy, fluoride varnish application, motivational interviewing, and anticipatory guidance.
Number of subjects: 0
Study 24330669 — intervention group
Group type: COMPARATOR
Intervention: Control group (delayed intervention)
Number of subjects: 0
Study 22167034 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided tissue regeneration with collagen membrane (CM) combined with autogenous bone graft (test group 1)
Number of subjects: 22
Study 22167034 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided tissue regeneration with collagen membrane (CM) combined with autogenous bone mixed with bioactive glass (test group 2)
Number of subjects: 22
Study 22167034 — intervention group
Group type: COMPARATOR
Intervention: Guided tissue regeneration with collagen membrane (CM) alone (control group)
Number of subjects: 22
Study 18498033 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine triphosphate (ATP) stress
Number of subjects: 38
Study 18498033 — intervention group
Group type: COMPARATOR
Intervention: Exercise stress
Number of subjects: 38
Study 16739748 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent prostate brachytherapy
Number of subjects: 0
Study 16739748 — intervention group
Group type: COMPARATOR
Intervention: Supplemental external-beam radiation therapy (XRT)
Number of subjects: 0
Study 14668071 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (20 microg/kg) administered by nasal spray
Number of subjects: 0
Study 14668071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10901307 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin
Number of subjects: 10929
Study 10901307 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose heparin
Number of subjects: 10929
Study 10901307 — intervention group
Group type: EXPERIMENTAL
Intervention: Any prophylactic agent
Number of subjects: 10929
Study 10901307 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 10929
Study 10901307 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumatic compression
Number of subjects: 10929
Study 8642235 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial intervention for 2 years
Number of subjects: 149
Study 8642235 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 149
Study 8642235 — intervention group
Group type: COMPARATOR
Intervention: Multifactorial intervention and Control group
Number of subjects: 149
Study 1519588 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (50 mg/day) for 1 month
Number of subjects: 61
Study 1519588 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 6375329 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 29
Study 6375329 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 29
Study 30847753 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear appeals (low, moderate, high)
Number of subjects: 117
Study 29629603 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream applied for 30 minutes
Number of subjects: 361
Study 29629603 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream applied for 60 minutes
Number of subjects: 361
Study 29629603 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 361
Study 26698015 — intervention group
Group type: EXPERIMENTAL
Intervention: Power-based resistance training (PWT)
Number of subjects: 26
Study 26698015 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 26
Study 25168927 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic haloperidol 1 mg twice daily for a maximum of seven consecutive days
Number of subjects: 390
Study 25168927 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 390
Study 25168927 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic haloperidol
Number of subjects: 390
Study 22901557 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (Omacor, 3 g/d) for 6 months
Number of subjects: 47
Study 22901557 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 47
Study 21144033 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education sessions for residents in their homes, appointment of a health ambassador among the staff, and a study circle for staff in each residence.
Number of subjects: 0
Study 21144033 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in work routines in the residences assessed by a questionnaire to managers.
Number of subjects: 0
Study 17602297 — intervention group
Group type: EXPERIMENTAL
Intervention: Community demographics (poverty)
Number of subjects: 137
Study 17602297 — intervention group
Group type: EXPERIMENTAL
Intervention: Social capital
Number of subjects: 137
Study 17602297 — intervention group
Group type: EXPERIMENTAL
Intervention: Team member attitudes towards prevention
Number of subjects: 137
Study 17602297 — intervention group
Group type: EXPERIMENTAL
Intervention: Team members' views of the acceptability of teen alcohol use
Number of subjects: 137
Study 15629339 — intervention group
Group type: EXPERIMENTAL
Intervention: Superficial cervical block
Number of subjects: 125
Study 15629339 — intervention group
Group type: COMPARATOR
Intervention: Combined cervical block
Number of subjects: 125
Study 15629339 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 125
Study 11929646 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert contraceptive advice (participants, n = 771)
Number of subjects: 1637
Study 11929646 — intervention group
Group type: COMPARATOR
Intervention: Standard advice routinely given in that setting (controls, n = 866)
Number of subjects: 1637
Study 10022402 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 390
Study 10022402 — intervention group
Group type: COMPARATOR
Intervention: Nonlactating women
Number of subjects: 390
Study 7756797 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal pethidine
Number of subjects: 44
Study 7756797 — intervention group
Group type: COMPARATOR
Intervention: Control (no pethidine)
Number of subjects: 44
Study 2274758 — intervention group
Group type: EXPERIMENTAL
Intervention: Right visual half-field group (isolation and repression)
Number of subjects: 84
Study 2274758 — intervention group
Group type: EXPERIMENTAL
Intervention: Left visual half-field measure (regressive strategies)
Number of subjects: 84
Study 2274758 — intervention group
Group type: COMPARATOR
Intervention: High creative subjects
Number of subjects: 84
Study 2274758 — intervention group
Group type: EXPERIMENTAL
Intervention: High creative persons
Number of subjects: 84
Study 7308331 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 200 mg in ordinary tablets
Number of subjects: 8
Study 7308331 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 200 mg in slow-release tablets
Number of subjects: 8
Study 7308331 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 7308331 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (beta 2-receptor stimulating agent)
Number of subjects: 8
Study 31402235 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow regimen
Number of subjects: 252
Study 31402235 — intervention group
Group type: EXPERIMENTAL
Intervention: Expanded gram-negative regimen
Number of subjects: 252
Study 31402235 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoroquinolone-based regimen
Number of subjects: 252
Study 30803084 — intervention group
Group type: EXPERIMENTAL
Intervention: CaringGuidance plus usual care
Number of subjects: 100
Study 30803084 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 100
Study 27930941 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG‐IUS 12
Number of subjects: 2885
Study 26369489 — intervention group
Group type: EXPERIMENTAL
Intervention: salivary substitute as an adjunct to scaling and root planing (SRP)
Number of subjects: 40
Study 26369489 — intervention group
Group type: COMPARATOR
Intervention: scaling and root planing (SRP)
Number of subjects: 40
Study 24372304 — intervention group
Group type: EXPERIMENTAL
Intervention: 3K3A-APC at 6, 30, 90, 180, 360, 540 or 720 µg/kg
Number of subjects: 64
Study 24372304 — intervention group
Group type: EXPERIMENTAL
Intervention: 3K3A-APC at 90, 180, 360, or 540 µg/kg
Number of subjects: 64
Study 24372304 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 21392372 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment plus Manual Lymphatic Drainage
Number of subjects: 58
Study 21392372 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (skin care, exercise, compression measures, bandages for one month, and compression garments)
Number of subjects: 58
Study 19711495 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally tailored cervical cancer education program in three weekly sessions
Number of subjects: 398
Study 19711495 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 398
Study 18685533 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer monitoring for 28 consecutive days
Number of subjects: 212
Study 18685533 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer monitoring for 1 week
Number of subjects: 212
Study 16125536 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone 4 mg daily
Number of subjects: 40
Study 16125536 — intervention group
Group type: COMPARATOR
Intervention: Control (no rosiglitazone)
Number of subjects: 40
Study 12163785 — intervention group
Group type: EXPERIMENTAL
Intervention: Innovative pulse oximeter (IPO)
Number of subjects: 86
Study 12163785 — intervention group
Group type: COMPARATOR
Intervention: Conventional pulse oximeter (CPO)
Number of subjects: 86
Study 10022641 — intervention group
Group type: EXPERIMENTAL
Intervention: Plantago ovata seeds (10 g b.i.d.)
Number of subjects: 105
Study 10022641 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesalamine (500 mg t.i.d.)
Number of subjects: 105
Study 10022641 — intervention group
Group type: EXPERIMENTAL
Intervention: Plantago ovata seeds plus mesalamine (same doses)
Number of subjects: 105
Study 10022641 — intervention group
Group type: EXPERIMENTAL
Intervention: Plantago ovata seeds
Number of subjects: 105
Study 10022641 — intervention group
Group type: COMPARATOR
Intervention: Mesalamine
Number of subjects: 105
Study 7496561 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine 1 mg (antimuscarinic)
Number of subjects: 7
Study 7496561 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicergoline 2.5 mg (alpha blocker)
Number of subjects: 7
Study 7496561 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol 40 mg (beta 1 blocker)
Number of subjects: 7
Study 7496561 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 2351321 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic irradiation + cyclophosphamide
Number of subjects: 118
Study 2351321 — intervention group
Group type: COMPARATOR
Intervention: Abdominal irradiation
Number of subjects: 118
Study 98127 — intervention group
Group type: EXPERIMENTAL
Intervention: Penfluridol, 20 to 160 mg orally once each week
Number of subjects: 60
Study 98127 — intervention group
Group type: COMPARATOR
Intervention: Fluphenazine decanoate, 0.5 to 4 ml every two weeks
Number of subjects: 60
Study 98127 — intervention group
Group type: COMPARATOR
Intervention: Placebo (retrospective comparison)
Number of subjects: 60
Study 30311042 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRI (in L2 for ECX arm)
Number of subjects: 416
Study 30311042 — intervention group
Group type: EXPERIMENTAL
Intervention: ECX (in L2 for FOLFIRI arm)
Number of subjects: 416
Study 30311042 — intervention group
Group type: COMPARATOR
Intervention: L2 treatment (compared to L1 only)
Number of subjects: 416
Study 30311042 — intervention group
Group type: EXPERIMENTAL
Intervention: Age < 60 years at diagnosis
Number of subjects: 416
Study 30311042 — intervention group
Group type: EXPERIMENTAL
Intervention: ECOG score 2 before L2
Number of subjects: 416
Study 30311042 — intervention group
Group type: EXPERIMENTAL
Intervention: Age ≥ 60 years at diagnosis and ECOG score 0/1 before L2
Number of subjects: 416
Study 28361371 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker up-titration over 12 weeks
Number of subjects: 530
Study 25719757 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 42
Study 25719757 — intervention group
Group type: COMPARATOR
Intervention: Normal saline solution
Number of subjects: 42
Study 23752260 — intervention group
Group type: EXPERIMENTAL
Intervention: CareCall (telehealth intervention)
Number of subjects: 142
Study 23752260 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 142
Study 21488802 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose 100 mg three times daily
Number of subjects: 66
Study 21488802 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 17989314 — intervention group
Group type: EXPERIMENTAL
Intervention: Stem-cell transplantation (SCT) from an alternative donor
Number of subjects: 205
Study 17989314 — intervention group
Group type: COMPARATOR
Intervention: Immunosuppressive therapy (IST) - second course
Number of subjects: 205
Study 16549747 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdebrider intracapsular tonsillectomy (MT)
Number of subjects: 74
Study 16549747 — intervention group
Group type: COMPARATOR
Intervention: Monopolar electrocautery tonsillectomy (ET)
Number of subjects: 74
Study 12882864 — intervention group
Group type: EXPERIMENTAL
Intervention: AC2993 (0.08 micro g/kg)
Number of subjects: 109
Study 12882864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study 11077932 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc sulphate (177 mg/kg/day in three divided doses equivalent to 40 mg elemental zinc)
Number of subjects: 80
Study 11077932 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 9206049 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy
Number of subjects: 404
Study 9206049 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative chemotherapy
Number of subjects: 404
Study 9206049 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (Control)
Number of subjects: 404
Study 1341621 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-randomized comparison groups
Number of subjects: 0
Study 1341621 — intervention group
Group type: COMPARATOR
Intervention: Current device (implied control)
Number of subjects: 0
Study 6209506 — intervention group
Group type: EXPERIMENTAL
Intervention: Tyramine, 15.0 micrograms/kg/min for 30 min
Number of subjects: 0
Study 6209506 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold exposure at 4 degrees C for 30 min
Number of subjects: 0
Study 6209506 — intervention group
Group type: COMPARATOR
Intervention: Propranolol, 160 mg (single oral dose)
Number of subjects: 0
Study 30660582 — intervention group
Group type: COMPARATOR
Intervention: Compression stockings (compared with placebo)
Number of subjects: 6162
Study 30660582 — intervention group
Group type: COMPARATOR
Intervention: Long-term compression (compared with short-term compression)
Number of subjects: 6162
Study 30660582 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended tinzaparin (LMWH)
Number of subjects: 6162
Study 30660582 — intervention group
Group type: COMPARATOR
Intervention: Procedural thrombolysis
Number of subjects: 6162
Study 30660582 — intervention group
Group type: COMPARATOR
Intervention: Streptokinase (medical thrombolysis)
Number of subjects: 6162
Study 30185196 — intervention group
Group type: EXPERIMENTAL
Intervention: Lantern-shaped screw loaded with autogenous bone
Number of subjects: 32
Study 30185196 — intervention group
Group type: COMPARATOR
Intervention: Control group (core decompression and autogenous bone graft)
Number of subjects: 32
Study 27079676 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care consultation (PCC)
Number of subjects: 85
Study 27079676 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 85
Study 25318980 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education package (comprising education and counselling of mothers, training community-based nutrition counsellors, sensitisation meetings with health staff and family members, supervision of community-based nutrition counsellors)
Number of subjects: 0
Study 25318980 — intervention group
Group type: COMPARATOR
Intervention: Routine health education offered monthly by health staff at health facilities
Number of subjects: 0
Study 25318980 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education package
Number of subjects: 0
Study 22071199 — intervention group
Group type: EXPERIMENTAL
Intervention: Low calorie diets and a program of exercises
Number of subjects: 150
Study 22071199 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 150
Study 19730861 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascularised bone graft from the dorsal and distal aspect of the radius (group I)
Number of subjects: 46
Study 19730861 — intervention group
Group type: COMPARATOR
Intervention: Conventional non‐vascularised bone graft from the distal radius (group II)
Number of subjects: 46
Study 18563969 — intervention group
Group type: EXPERIMENTAL
Intervention: Most preferred music
Number of subjects: 0
Study 18563969 — intervention group
Group type: EXPERIMENTAL
Intervention: Least preferred music
Number of subjects: 0
Study 18563969 — intervention group
Group type: COMPARATOR
Intervention: No music
Number of subjects: 0
Study 18563969 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity exercise
Number of subjects: 0
Study 18563969 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise
Number of subjects: 0
Study 18563969 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity exercise
Number of subjects: 0
Study 16018851 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 96 mg/day
Number of subjects: 531
Study 16018851 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 192 mg/day
Number of subjects: 531
Study 16018851 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 531
Study 15208937 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Molecular Weight Chitosan (LMWCh)
Number of subjects: 0
Study 15208937 — intervention group
Group type: EXPERIMENTAL
Intervention: High Molecular Weight Chitosan (HMWCh)
Number of subjects: 0
Study 15208937 — intervention group
Group type: COMPARATOR
Intervention: Hexetidine
Number of subjects: 0
Study 15208937 — intervention group
Group type: COMPARATOR
Intervention: Triclosan
Number of subjects: 0
Study 10335764 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose simvastatin (80 mg)
Number of subjects: 842
Study 10335764 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose simvastatin (40 mg)
Number of subjects: 842
Study 10335764 — intervention group
Group type: COMPARATOR
Intervention: High-dose atorvastatin (40 mg)
Number of subjects: 842
Study 10335764 — intervention group
Group type: COMPARATOR
Intervention: Low-dose atorvastatin (20 mg)
Number of subjects: 842
Study 8935744 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamine hydrochloride (vitamin B1) 100 mg orally, daily for 90 days
Number of subjects: 556
Study 8935744 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 556
Study 1708499 — intervention group
Group type: EXPERIMENTAL
Intervention: buprenorphine
Number of subjects: 20
Study 1708499 — intervention group
Group type: COMPARATOR
Intervention: morphine
Number of subjects: 20
Study 1708499 — intervention group
Group type: COMPARATOR
Intervention: meperidine
Number of subjects: 20
Study 6811511 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate intake with potassium supplementation
Number of subjects: 4
Study 6811511 — intervention group
Group type: COMPARATOR
Intervention: High carbohydrate intake without potassium supplementation
Number of subjects: 4